Cargando…

The effects of cerebral oximetry in mechanically ventilated newborns: a protocol for the SafeBoosC-IIIv randomised clinical trial

BACKGROUND: The SafeBoosC project aims to test the clinical value of non-invasive cerebral oximetry by near-infrared spectroscopy in newborn infants. The purpose is to establish whether cerebral oximetry can be used to save newborn infants’ lives and brains or not. Newborns contribute heavily to tot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vestager, Maria Linander, Hansen, Mathias Lühr, Rasmussen, Marie Isabel, Hahn, Gitte Holst, Hyttel-Sørensen, Simon, Pellicer, Adelina, Heuchan, Anne Marie, Hagmann, Cornelia, Dempsey, Eugene, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Fuchs, Hans, Tkaczyk, Jakub, Mintzer, Jonathan, Fumagalli, Monica, Nesargi, Saudamini, Fredly, Siv, Szczapa, Tomasz, Gluud, Christian, Jakobsen, Janus Christian, Greisen, Gorm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612349/ https://www.ncbi.nlm.nih.gov/pubmed/37898759 http://dx.doi.org/10.1186/s13063-023-07699-x

Ejemplares similares

Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
por: Rasmussen, Marie Isabel, et al.
Publicado: (2023)

Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
por: Hansen, Mathias Lühr, et al.
Publicado: (2019)

Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
por: Olsen, Markus Harboe, et al.
Publicado: (2021)

Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial
por: Plomgaard, Anne M., et al.
Publicado: (2017)

Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown
por: Rasmussen, Marie Isabel, et al.
Publicado: (2021)

The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings
por: Riera, Joan, et al.
Publicado: (2016)

Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments
por: Plomgaard, Anne M, et al.
Publicado: (2016)

Pilot test of an online training module on near-infrared spectroscopy monitoring for the randomised clinical trial SafeBoosC-III
por: Hansen, Mathias Lühr, et al.
Publicado: (2020)

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life
por: Plomgaard, Anne M., et al.
Publicado: (2018)

The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury
por: Plomgaard, Anne M., et al.
Publicado: (2016)

Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
por: Olsen, Markus Harboe, et al.
Publicado: (2023)

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial
por: Plomgaard, Anne Mette, et al.
Publicado: (2022)

A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2013)

Cerebral Oximetry in Preterm Infants–To Use or Not to Use, That Is the Question
por: Greisen, Gorm, et al.
Publicado: (2022)

The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis
por: Hansen, Mathias Lühr, et al.
Publicado: (2021)

Assessment of BPH/BOO
por: Mangera, Altaf, et al.
Publicado: (2014)

UV spectrum of $\lambda$ Boo
por: Gerbaldi, M, et al.
Publicado: (1995)

Management of the complications of BPH/BOO
por: Speakman, Mark J., et al.
Publicado: (2014)

“Boo-Khar”—India Fever
por: Condict, Alice B.
Publicado: (1889)

MicroBooNE and the $\nu_e$ Interpretation of the MiniBooNE Low-Energy Excess
por: Argüelles, C.A., et al.
Publicado: (2021)

Boo-boos as the building blocks of pain expression: An observational examination of parental responses to everyday pain in toddlers
por: Noel, Melanie, et al.
Publicado: (2018)

Non-Hormonal treatment of BPH/BOO
por: Osman, Nadir I., et al.
Publicado: (2014)

Modelling solar-like oscillations in $\eta$ Boo
por: Christensen-Dalsgaard, J, et al.
Publicado: (1994)

DSLs in Boo: domain-specific languages in .NET
por: Rahien, Ayende
Publicado: (2010)

Fermilab: MiniBooNE opens the box
Publicado: (2007)

Draft Genome Sequence of a Novel Species of Halococcus (Strain IIIV-5B), an Endophytic Archaeon Isolated from the Leaf Tissue of Avicennia germinans
por: Zayas-Rivera, Jeysika, et al.
Publicado: (2020)

Near-surface effects in modelling oscillations of $\eta$ Boo
por: Christensen-Dalsgaard, J, et al.
Publicado: (1995)

The LSND puzzle in the light of MiniBooNE results
por: Schwetz, Thomas, et al.
Publicado: (2008)

More Ingredients for an Altarelli Cocktail at MiniBooNE
por: Kelly, Kevin J., et al.
Publicado: (2022)

Do pathogen effectors play peek-a-boo?
por: Bakkeren, Guus, et al.
Publicado: (2014)

Dark Sectors and MiniBooNE Low Energy Excess
por: Hoefken Zink, Jaime
Publicado: (2023)

CCD photometry of the $\delta$-Scuti star $\kappa^{2}$Boo
por: Frandsen, S, et al.
Publicado: (1995)

Investigation of the MicroBooNE neutrino cross sections on Argon
por: Martini, M., et al.
Publicado: (2022)

A Standard Model explanation for the MiniBooNE anomaly
por: Ioannisian, Ara, et al.
Publicado: (2021)

Search for a Low Energy Excess in MicroBooNE
por: Foppiani, Nicolò
Publicado: (2019)

Comparison of efficacy of three devices of manual positive pressure ventilation: a mannequin-based study
por: Nimbalkar, Somashekhar M, et al.
Publicado: (2015)

Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial
por: Hyttel-Sorensen, Simon, et al.
Publicado: (2015)

A new analysis of the MiniBooNE low-energy excess
por: Giunti, C., et al.
Publicado: (2020)

Sterile neutrino oscillations after first MiniBooNE results
por: Maltoni, Michele, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_9vf0mq19bcjkm6dregp4ggvmaf